Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Role of Dietary Polyphenols in Alternating Dna Methylation in Cancer Publisher Pubmed



Qadir Nanakali NM1, 2 ; Maleki Dana P3 ; Sadoughi F3 ; Asemi Z3 ; Sharifi M4 ; Asemi R4 ; Yousefi B5, 6
Authors

Source: Critical Reviews in Food Science and Nutrition Published:2023


Abstract

Natural products such as curcumin, quercetin, and resveratrol have been shown to have antitumor effectsand several studies have examined their role in treating cancer, either alone or in combination with other chemotherapeutic drugs. These compounds are capable of affecting different cancer-related mechanisms, such as proliferation, inflammation, invasion, and metastasis. Along with all of the benefits of these agents, affecting epigenetic processes is one of the most important aspects of their impact. Epigenetic modifications can be categorized into three main processes that include DNA methylation, histone modification, and regulation of small non-coding RNAs. Therefore, targeting DNA methylation can be used as a cancer treatment strategy by identifying or developing methylation modulators. Herein, we take a look into the studies investigating the role of natural products (e.g. curcumin, resveratrol, epigallocatechin gallate (EGCG), and quercetin) in alternating the DNA methylation status of various cancer cells. We discuss how these compounds reduce the expression of enzymes mediating the methylation of tumor suppressor genes and thereby, increasing the expression of tumor suppressors while reactivating antitumor signaling pathways. © 2022 Taylor & Francis Group, LLC.
Other Related Docs
8. Microrna: A Novel Target of Curcumin in Cancer Therapy, Journal of Cellular Physiology (2018)
14. Epigenetics and Common Non Communicable Disease, Advances in Experimental Medicine and Biology (2019)
16. Epigenetic Regulation of Autophagy in Gastrointestinal Cancers, Biochimica et Biophysica Acta - Molecular Basis of Disease (2022)